Oncofetal Protein IMP3, a Molecular Marker for the Malignant Progression of Ovarian Serous Neoplasm

被引：0
|
作者：
Goodman, S. [1 ]
Yong, X. [1 ]
Lu, D. [1 ]
机构：
[1] Umass Mem Med Ctr, Worcester, MA USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1144
引用
收藏
页码：273A / 273A
页数：1
相关论文
共 50 条
  • [41] IMP3, a novel oncofetal protein that differentiates between benign endosalpingiosis and metastatic adenocarcinomas
    Garcia, M. T.
    Ganjei-Azar, P.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S76 - S77
  • [42] An oncofetal protein, IMP3: A novel biomarker to predict of tumor progression in the low grade Ta urothelial carcinoma of the bladder
    Mohanty, S. K.
    Lu, D. I.
    Dresser, K.
    Jiang, Z.
    LABORATORY INVESTIGATION, 2008, 88 : 171A - 171A
  • [43] IMP3 Expression in Serous Tumors of the Ovary
    Chiste, Marcela
    Alexis, John
    Recine, Monica
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (09) : 658 - 662
  • [44] IMP3, EGFR and E-Cadherin in High Grade Ovarian Serous Carcinomas To Predict Disease Progression and Survival
    Patel, D.
    Mohanty, S. K.
    Singh, K.
    Walsh, C.
    Silva, E. G.
    LABORATORY INVESTIGATION, 2012, 92 : 292A - 292A
  • [45] IMP3, EGFR and E-Cadherin in High Grade Ovarian Serous Carcinomas To Predict Disease Progression and Survival
    Patel, D.
    Mohanty, S. K.
    Singh, K.
    Walsh, C.
    Silva, E. G.
    MODERN PATHOLOGY, 2012, 25 : 292A - 292A
  • [46] IMP3 is an extremely poor prognostic marker for ovarian clear cell carcinoma
    Kobel, M.
    Xu, H.
    Bourne, P. A.
    Spoulding, B. O.
    Huntsman, D.
    Gilks, C. B.
    LABORATORY INVESTIGATION, 2008, 88 : 209A - 209A
  • [47] The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions
    Vercellini, Paolo
    Cribiu, Fulvia Milena
    Del Gobbo, Alessandro
    Carcangiu, Maria Luisa
    Somigliana, Edgardo
    Bosari, Silvano
    FERTILITY AND STERILITY, 2013, 99 (07) : 1974 - 1979
  • [48] Oncofetal Protein IMP3, a Diagnostic Biomarker To Distinguish Microcystic Adnexal Carcinoma from Syringoma
    Cornejo, K.
    Deng, A.
    LABORATORY INVESTIGATION, 2012, 92 : 118A - 118A
  • [49] IMP3 is an extremely poor prognostic marker for ovarian clear cell carcinoma
    Kobel, M.
    Xu, H.
    Bourne, P. A.
    Spoulding, B. O.
    Huntsman, D.
    Gilks, C. B.
    MODERN PATHOLOGY, 2008, 21 : 209A - 209A
  • [50] IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis
    Li, Dawei
    Yan, Dongwang
    Tang, Huamei
    Zhou, Chongzhi
    Fan, Junwei
    Li, Shuxia
    Wang, Xiaoliang
    Xia, Jun
    Huang, Fei
    Qiu, Guoqiang
    Peng, Zhihai
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) : 3499 - 3506
12345